Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 27, 2016

View Archived Issues

Pfizer discloses vanin-1 inhibitors

A-000830 is a promising novel small-molecule inhibitor of ecto-nucleotidase CD73

HTL-001 is highly cytotoxic to prostate and breast cancer cells in vitro and in vivo

Ono gains access to Ligand Pharmaceuticals' OmniAb platform

Bantam Pharmaceutical patents mRNA translation initiation inhibitors

Lead Pharma Cel Models and Sanofi disclose RORgamma modulators

GlaxoSmithKline and University of Dundee describe antiparasitic agents

Genticel and Genkyotex sign contribution agreement

First patient enrolled in LTX-315 anti-PD-1 combination study

RespireRx Pharmaceuticals announces positive results from phase IIb PACE study

RO-689921 is well tolerated in patients with solid tumors

Neothetics initiates phase II trial of LIPO-202 for the reduction of submental subcutaneous fat

Strongbridge Biopharma acquires U.S. rights to Keveyis from Taro

First patient enrolled in BioHaven's phase IIb/III study of BHV-4157

FDA grants approval to Spinraza for treatment of spinal muscular atrophy

FDA accepts betrixaban NDA for priority review, EMA validates MAA

Pluristem and NYBC to collaborate in developing PLX-R18 cell therapy

Tokai Pharmaceuticals and Otic Pharma enter definitive share purchase agreement

Biocartis announces RAS biomarker testing collaboration with Amgen in Europe

Phase IIb data support advancement of linaclotide colonic release-1 in IBS-C

Dipexium and PLx Pharma enter merger agreement

Synergy Pharmaceuticals reports topline results of second pivotal study of plecanatide in IBS-C

TiGenix submits responses to EMA regarding Cx-601 MAA

MSD seeks approval of additional indication for Keytruda in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...